TCI Wealth Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-60
Closed -$4K 2294
2020
Q4
$4K Hold
60
﹤0.01% 1049
2020
Q3
$3K Buy
60
+7
+13% +$293 ﹤0.01% 1056
2020
Q2
$2K Hold
53
﹤0.01% 1180
2020
Q1
$2K Hold
53
﹤0.01% 1161
2019
Q4
$2K Hold
53
﹤0.01% 1266
2019
Q3
$2K Hold
53
﹤0.01% 1203
2019
Q2
$3K Hold
53
﹤0.01% 962
2019
Q1
$3K Hold
53
﹤0.01% 982
2018
Q4
$3K Hold
53
﹤0.01% 949
2018
Q3
$3K Hold
53
﹤0.01% 985
2018
Q2
$2K Hold
53
﹤0.01% 1213
2018
Q1
$2K Hold
53
﹤0.01% 1063
2017
Q4
$2K Hold
53
﹤0.01% 1111
2017
Q3
$2K Hold
53
﹤0.01% 1040
2017
Q2
$2K Hold
53
﹤0.01% 1067
2017
Q1
$2K Hold
53
﹤0.01% 1021
2016
Q4
$1K Hold
53
﹤0.01% 1331
2016
Q3
$1K Hold
53
﹤0.01% 1338
2016
Q2
$1K Hold
53
﹤0.01% 1269
2016
Q1
$1K Buy
+53
New +$592 ﹤0.01% 1279

Other funds holding BEAT

TCI Wealth Advisors's BEAT Position: Q1 2021 in Review

TCI Wealth Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 60 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in BEAT in Q1 2016 and held it in 20 quarters. The position peaked at $4K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • TCI Wealth Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • TCI Wealth Advisors sold 60 BioTelemetry, Inc. shares in Q1 2021, an estimated $4K.
  • TCI Wealth Advisors first reported a position in BioTelemetry, Inc. in Q1 2016 and held it in 20 quarters.
  • TCI Wealth Advisors's BioTelemetry, Inc. position peaked at $4K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on TCI Wealth Advisors's 13F filing for Q1 2021, filed 29 Apr 2021.